The DNA damage response is essential for maintaining genome integrity and preventing various human diseases, many of which are characterized by pronounced neuropathology [1] [2] [3] . Although most components of this signaling pathway have been identified, their tissue-specific function for preventing characteristic disease-related pathology is unclear, as are the precise DNA lesions underpinning the etiology of these syndromes 1 . The nervous system is particularly at risk from DNA damage 4 , and endogenous DNA breaks occur spontaneously during development and in the mature brain [5] [6] [7] . One instance of defective DNA damage signaling is ataxia telangiectasia (A-T), a neurodegenerative syndrome associated with cancer susceptibility, immunodeficiency and radiosensitivity [8] [9] [10] .
a r t I C l e S
The DNA damage response is essential for maintaining genome integrity and preventing various human diseases, many of which are characterized by pronounced neuropathology [1] [2] [3] . Although most components of this signaling pathway have been identified, their tissue-specific function for preventing characteristic disease-related pathology is unclear, as are the precise DNA lesions underpinning the etiology of these syndromes 1 . The nervous system is particularly at risk from DNA damage 4 , and endogenous DNA breaks occur spontaneously during development and in the mature brain [5] [6] [7] . One instance of defective DNA damage signaling is ataxia telangiectasia (A-T), a neurodegenerative syndrome associated with cancer susceptibility, immunodeficiency and radiosensitivity [8] [9] [10] .
A-T results from dysfunction of ATM (ataxia telangiectasia, mutated), a serine/threonine protein kinase, which is required for the activation of cell cycle checkpoints, chromatin remodeling, DNA repair and apoptosis after DNA double-strand breaks 8, 10 . This is reinforced by the A-T-like neuropathology present when Mre11 is partially inactivated (resulting in A-T like disease, ATLD 11, 12 ); this factor is a component of the ATM-activating Mre11-Rad50-Nbs1 (MRN) DNA double-strand break sensor 9, 11, 13, 14 . ATM activation via the MRN complex is required for apoptosis of immature neural cells after DNA damage via p53 and Chk2 phosphorylation 5, 13, 15 , and failure to eliminate these damaged neuroprogenitors could predispose mature A-T tissue to later neurodegeneration. However, ATM's full neuroprotective repertoire in the nervous system remains elusive 16 .
Two neurodegenerative syndromes similar to A-T, ataxia with oculomotor apraxia (AOA1) and spinocerebellar ataxia with axonal neuropathy (SCAN1), result from defects in the DNA repair enzymes aprataxin (APTX) and tyrosyl-DNA phosphodiesterase 1 (TDP1), respectively. APTX and TDP1 function primarily during DNA single-strand break repair 11, [17] [18] [19] ; APTX is an adenyl hydrolase that resolves 5′-adenylation intermediates during DNA ligation, whereas TDP1 cleaves and processes 3′-end covalent Top1-DNA intermediates and DNA lesions formed by oxidative damage 11, 12, 18, 19 . To investigate etiologic connections between these diseases and A-T, we considered whether ATM function intersects single-strand break repair disorders. Because ATM has been implicated in the response to Top1 adducts [20] [21] [22] , which could increase levels of DNA damage, particularly DNA single-strand breaks, we determined whether ATM regulates Top1-induced damage in neural tissue. We found that a key function of ATM is to avert detrimental DNA lesions in both the developing and mature nervous system by preventing the accumulation of Top1ccs. This involved ubiquitinationand sumoylation-mediated turnover of Top1 to resolve Top1ccs, and was ATM kinase independent. Our results further implicate defective Top1 processing and the accumulation of neural DNA damage as causative for neuropathology in multiple neurodegenerative syndromes arising from mutation of DNA damage response factors.
RESULTS

ATM regulates Top1cc in neural tissue
Throughout neural development, cells encounter a variety of events that compromise genome integrity, among which is endogenous damage via Top1 malfunction during DNA replication and transcription 1, 12, [23] [24] [25] .
DNA damage is considered to be a prime factor in several spinocerebellar neurodegenerative diseases; however, the DNA lesions underpinning disease etiology are unknown. We observed the endogenous accumulation of pathogenic topoisomerase-1 (Top1)-DNA cleavage complexes (Top1ccs) in murine models of ataxia telangiectasia and spinocerebellar ataxia with axonal neuropathy 1. We found that the defective DNA damage response factors in these two diseases cooperatively modulated Top1cc turnover in a non-epistatic and ATM kinase-independent manner. Furthermore, coincident neural inactivation of ATM and DNA single-strand break repair factors, including tyrosyl-DNA phosphodiesterase-1 or XRCC1, resulted in increased Top1cc formation and excessive DNA damage and neurodevelopmental defects. Notably, direct Top1 poisoning to elevate Top1cc levels phenocopied the neuropathology of the mouse models described above. Our results identify a critical endogenous pathogenic lesion associated with neurodegenerative syndromes arising from DNA repair deficiency, indicating that genome integrity is important for preventing disease in the nervous system. npg a r t I C l e S Top1 alters DNA topology and relaxes DNA supercoiling by breaking and rejoining one strand of DNA, and thousands of these transient Top1ccs form during normal cellular function. However, a portion of these can persist in genomic DNA, and when trapped, a Top1cc includes a DNA strand break, which is a direct threat to cell survival 12, 15, 23 . The anticancer agent camptothecin (CPT) is effective at killing replicating cells because it promotes accumulation of Top1ccs that are converted into lethal DNA double-strand breaks following collision with replication forks 23, 24 . CPT-induced Top1cc and associated DNA breaks during transcription can activate ATM to initiate a DNA damage response (DDR), which is important to prevent genome damage to cells during proliferation 21, 22, 26 . Thus, removal of trapped Top1 is critical to avoid DNA damage accumulation and resultant sequela.
Loss of TDP1, whose function is required to repair Top1-DNA complexes via cleavage of the covalent Top1-DNA phosphodiester bond, leads to the neurodegenerative disease SCAN1. Thus, we examined brain tissue from Tdp1 −/− mice 27 to measure the endogenous levels of Top1cc using a modified immune complex of enzyme (ICE) assay 28, 29 (Fig. 1a) in a setting in which Top1 removal from DNA is compromised. We observed high levels of Top1cc in Tdp1 −/− neural tissue compared with control tissue, particularly during early development (Fig. 1) . Because of phenotypic similarities between SCAN1 and A-T 1 , we assessed Top1cc levels in the nervous system of Atm −/− mice. We found that, at embryonic day 12.5 (E12.5), a highly proliferative stage in embryonic brain development, ATM-deficient neural tissue had accumulated substantial Top1cc levels (Fig. 1c) . Although Top1cc levels were increased during early brain development in both Tdp1 −/− and Atm −/− embryos, they were reduced after E18.5, suggesting these complexes increase during rapid embryonic proliferation rates. Following birth and into adulthood, elevated Top1cc levels persisted in Atm −/− and Tdp1 −/− cerebella compared with wild-type controls (Fig. 1c,e) . At 1 year of age, both Atm −/− and Tdp1 −/− cerebella showed higher levels of Top1cc, indicating that loss of either of these factors perturb the steady-state levels of Top1-DNA complexes (Fig. 1e) . Increased Top1cc did not reflect different Top1 protein levels, as these were equivalent among all genotypes (Fig. 1b,d) . We also examined Topoisomerase-2α-DNA adducts (Top2cc) and found that, unlike Top1, levels of these complexes were similar between control, Tdp1 −/− and Atm −/− cerebellum (data not shown). These data indicate that both ATM and Tdp1 are required to prevent Top1cc accumulation in the nervous system. Atm −/− neural cells accumulate Top1cc-associated DNA damage Top1ccs involve DNA strand breaks, and the persistence of this complex predicts increased amounts of DNA damage 23, 30 . To determine whether Top1cc accumulation is associated with increased DNA strand breaks, we compared DNA repair rates in Atm −/− and Tdp1 −/− cells under conditions that promote the formation of these complexes, using the Top1 poison camptothecin (CPT) 26, 31 . To measure levels of DNA damage, we used the alkaline comet assay. We found that quiescent Atm −/− astrocytes accumulated Top1-dependent breaks at levels threefold higher than wild-type cells after CPT treatment, although at lower levels than Tdp1 −/− astrocytes (Fig. 2a) . Because cells are non-replicating, DNA breaks from trapped Top1cc are mostly single-stranded breaks. In contrast, astrocytes deficient in the ATMrelated DNA-dependent protein kinase, catalytic subunit (DNA-PKcs, Prkdc), repaired Top1-induced DNA damage at similar levels as wildtype astrocytes, indicating the relative specificity of the Atm −/− defect (Fig. 2a) . In addition, cells derived from a mouse model of ATLD (Mre11 ATLD/ATLD ) also failed to show a repair defect after CPT treatment, indicating that the role of ATM in preventing Top1-associated strand breaks is not Mre11-dependent (data not shown). We also confirmed that DNA breaks in these non-replicating cells were a result of transcription-associated Top1 damage 21, 22, 32 , as the transcription inhibitor 5,6-dichloro-1-β-d-ribofuranosylbenzimidazole abrogated CPT-induced DNA damage (Supplementary Fig. 1 ).
ATM has been implicated in the regulation of Tdp1 activity 33, 34 . We therefore assessed Tdp1 enzymatic activity in wild-type and Atm −/− brains. Quantification of the cleavage rate of an oligonucleotide substrate that mimics the Top1 protein-linked DNA 3′-terminus revealed that there was no difference in Tdp1-dependent product formation in Atm −/− cerebellar extracts compared to wild type, indicating that ATM does not affect Tdp1 enzymatic activity (Supplementary Fig. 2 ). This suggests that the role of ATM in regulating Top1cc is not mediated by Tdp1. npg a r t I C l e S
The kinase activity of ATM is critical for phosphorylation of various substrates that activate cell cycle arrest or apoptosis after DNA damage 8, 10 . We determined whether ATM kinase activity was necessary to prevent Top1cc-associated DNA strand breaks. Using the KU55933 ATM inhibitor 35 (ATMi), we compared Atm −/− astrocytes to ATMitreated wild-type astrocytes in the presence of CPT. Unlike Atm −/− astrocytes, ATMi-treated wild-type astrocytes showed normal DNA repair profiles (Fig. 2b) . Inhibition of ATM kinase activity in these experiments was confirmed by abrogation of post-translational modification of Chk2 and p53 after DNA damage (Fig. 2b) . These data imply that an aspect of the ATM protein, independent of ATM kinase activity, mediates ATM-dependent Top1cc removal to allow DNA repair.
In addition to the specificity of CPT toward Top1, various DNA lesions including single-strand breaks and abasic sites can also result in increased Top1cc levels that are irreversible 23 . We compared the relative effects of other genotoxins toward Top1cc accumulation and found that the loss of ATM or Tdp1 also increased Top1cc formation after ionizing radiation (IR), H 2 O 2 or methylmethane sulfonate (MMS; Fig. 2c) . Correspondingly, DNA damage in Atm −/− or Tdp1 −/− astrocytes was increased compared with wild-type cells after treatment with these genotoxins (Fig. 2d) . Atm −/− cerebellar granule neurons also showed an approximately threefold higher level of unrepaired DNA breaks after IR than did wild-type counterparts (Fig. 2e) . Tdp1 −/− granule neurons also showed elevated DNA breaks after IR, although the levels were relatively less than the comparative threefold increase observed over Atm −/− astrocytes (Fig. 2d) ; this possibly reflects intrinsic cell-type differences or cell culture effects. These data indicate that various types of DNA damage, including oxidative lesions, can increase Top1cc formation, compromising DNA integrity after ATM or Tdp1 loss. Notably, the antioxidant N-acetylcysteine reduced the levels of DNA breaks after CPT in either Atm −/− or Tdp1 −/− astrocytes, suggesting that oxidative stressinduced DNA breaks can exacerbate damage by trapping Top1ccs (Supplementary Fig. 3 ). Treatment conditions consisted of 14 µM CPT for 60 min at 37 °C, 20 Gy IR followed by 60 min recovery at 37 °C, 150 µM H 2 O 2 for 5 min at 4 °C followed by 60 min recovery at 37 °C, and 0.20 mg ml −1 MMS for 10 min at 37 °C. Top1ccs were identified by blotting genomic DNA with antibody to Top1 and gDNA levels were assessed by re-probing with 32 P-labeled mouse embryonic stem cell genomic DNA ( 32 P-DNA). (d) Alkaline comet analysis of quiescent Atm −/− astrocytes showed defective DNA single-strand break repair after treatments listed in c. For each in vitro comet assay, 100 cells per comet corresponding to each genotype and treatment were analyzed and experiments were performed in triplicate (total of n = 300 cells per genotype per treatment). (e) In vivo comet analysis comparing relative DNA strand break repair rates of control, Atm −/− and Tdp1 −/− cerebellar granule cell neurons following IR (15 Gy) and a 30-min recovery. Bar graphs represent mean comet tail moments from experiments that were repeated in duplicate (two mice per treatment) with cells isolated from each cerebella also measured in duplicate (total n = 400 independent comet tail moments measured per line/treatment); error bars represent s.e.m. Scatter plots indicate representative cellular comet tail moments from each corresponding cell and treatment type. *P < 0.0001. ATM regulates DNA damage-dependent Top1 degradation Removal of trapped Top1cc is associated with proteasome-mediated Top1 degradation, which involves protein modification by ubiquitination and sumoylation, with Tdp1 cleaving the Top1 peptide from DNA 21, 23, 30, 36 . To determine whether ATM modulates Top1cc levels via Top1 degradation, we examined the effect of the proteasome inhibitor MG132 after CPT in ATM-deficient and control cells. We found that total Top1 levels were decreased in control cells after CPT, but less so in Atm −/− cells (Fig. 3a) . Consistent with the CPT-induced decrease in Top1 being proteasome dependent, co-treatment with MG132 and CPT elevated Top1 and Top1cc levels in control cells by 4-5-fold (Fig. 3a) . In contrast, Top1 and Top1cc levels in Atm −/− cells were only marginally increased after MG132 treatment, suggesting that ATM modulates proteasome-mediated Top1 turnover (Fig. 3a) . Accordingly, under these experimental conditions, elevated Top1cc levels after MG132 and CPT treatment resulted in a marked increase in DNA breaks in control astrocytes (Fig. 3b) . Notably, MG132 treatment resulted in levels of DNA damage in control cells that were similar to those in Atm −/− cells. These data imply that ATM has a predominant role in directing proteasome-mediated turnover of Top1 in trapped Top1cc. In addition, proteasome inhibition also attenuated ATM signaling in wild-type cells after CPT, as indicated by reduced ATM (p-ser-1987) and Kap1 (p-ser-824) phosphorylation (Fig. 3c) .
We also compared the above results (in murine cells) to human A-T cells. We again found a marked reduction in total Top1 protein in CPTtreated control cells, compared with an approximately fourfold higher level of Top1 in the CPT-treated A-T counterparts, consistent with a requirement for ATM in Top1 turnover (Supplementary Fig. 4) . Consistent with these results, ICE assays revealed that more Top1ccs were trapped in A-T cells than in wild-type controls ( Supplementary  Fig. 4 ). Co-treatment of control cells with ATMi and CPT resulted in Top1 downregulation comparable to CPT-only treatment alone, indicating that, similar to our earlier data (Fig. 2) , Top1 downregulation is not ATM kinase dependent (Supplementary Fig. 4) . Collectively, these data support ATM as a key regulator of Top1 degradation, acting in a kinase-independent manner after CPT.
To understand how ATM modulates Top1 turnover, we examined the ubiquitination and sumoylation status of Top1, as both modifications are important for turnover of this protein 21, 36, 37 . Analysis of Top1 immunoprecipitates from CPT-treated cells revealed ubiquitinated Top1 in control cells (Fig. 3d) , but a marked reduction of ubiquitinated Top1 in A-T cells. Furthermore, Top1 immunoprecipitates showed a characteristic Top1-immunoreactive ladder in control cells (Fig. 3d,e) , reflecting post-translationally modified Top1 (Top1 PTM ), whereas this laddering was reduced in A-T cells. These high molecular weight Top1 bands also bound antibody to SUMO1 after CPT treatment, and, similarly, this Top1 pSUMO1 immunoreactivity was markedly reduced in A-T cells (Fig. 3e) . Co-treatment of control cells with ATMi and CPT revealed similar Top1 laddering, confirming that ATM kinase activity is dispensable for these modifications ( Fig. 3d-f) . We also found that knockdown of ATM, but not TDP1, reduced sumoylation of Top1 after CPT treatment in human cells ( Supplementary Fig. 5 ). Collectively, these results indicate that ATM regulates Top1 degradation in response to DNA damage in a manner independent of ATM kinase activity or TDP1 to attenuate Top1cc levels, thereby preventing DNA damage.
ATM is essential for DNA damage signaling from trapped Top1
Given that a prime role of ATM is as a serine/threonine protein kinase [8] [9] [10] , it was unexpected that this enzymatic activity was dispensable for Top1cc regulation and DNA strand break repair. A prominent feature of DNA damage signaling is the phosphorylation of histone H2AX on serine 139 by ATM or other related kinases (for example, Prkdc) 10 as an early event in establishing the DDR. Thus, we monitored the formation of phosphorylated histone H2AX (γH2AX) in response to CPT and other genotoxins using quiescent primary cells to avoid replication-associated damage. We found a pronounced defect in the induction of γH2AX after CPT treatment specifically in Atm −/− cells compared with Tdp1 −/− , Prkdc −/− or wildtype counterparts. This indicates that ATM is uniquely required for DNA damage signaling after CPT (Fig. 4a) ; comparable results using CPT have also been observed in postmitotic neurons 22 . In contrast to CPT, IR induced similar levels of γH2AX in all of the genotypes examined (Fig. 4a) . CPT-induced γH2AX foci also did not form in Atm −/− murine embryonic fibroblasts (MEFs) or A-T fibroblasts ( Fig. 4b and Supplementary Fig. 6 ). In addition, analysis of Atm −/− ; Tdp1 −/− double knockout cells revealed that γH2AX formation in response to CPT is dependent on ATM, even after Tdp1 inactivation (Fig. 4b) . However, CPT-induced γH2AX occurred at similar levels as in controls in cells from the A-T-related disease Nijmegen Breakage syndrome (NBS; Fig. 4c and Supplementary Fig. 6 ) and Mre11 ATLD/ATLD (data not shown), indicating that ATM-dependent phosphorylation of H2AX after CPT is not MRN dependent. We also examined γH2AX formation in Atm −/− cells after treatment with dual genotoxins by co-treating with CPT and bleomycin. Despite bleomycin activating γH2AX in Atm −/− cells, pre-treatment with CPT resulted in minimal bleomycin-induced γH2AX formation, implying that CPT-induced damage suppresses DNA damage signaling from ATM-related kinases (Fig. 4d,e) . However, after CPT washout (a 30-min CPT pulse followed by a 120-min recovery), γH2AX formed in Atm −/− cells and at higher levels in Atm −/− ; Tdp1 −/− astrocytes, and these foci were suppressed by the Prkdc inhibitor NU7441 (Fig. 4f) . Because replication-associated breaks don't occur in these quiescent cells, the DNA-dependent protein kinase (Prkdc) likely becomes activated as Top1cc lesions are processed. Collectively, our findings suggest a bi-modal response of ATM to CPT-induced DNA damage; ATM kinase activity is essential for DNA damage signaling, as shown by γH2AX formation after CPT treatment, whereas DNA repair (resolution of Thus, these data show that ATM has a unique role, independent of Tdp1, in responding to Top1cc-induced DNA damage.
Synthetic lethality occurs after dual inactivation of ATM and Tdp1
Although the Atm −/− brain accumulates Top1cc, these mice retain apparently normal neurological function and exhibit no overt neuropathology 38 . A similar situation is found with Tdp1 −/− mice 27 . We reasoned that if ATM and Tdp1 independently regulate Top1cc, intercrossing Atm −/− and Tdp1 −/− mice would increase the levels of trapped Top1cc in the brain, and this should be an effective means to assess the in vivo effect of this lesion. We observed a >90% reduction in viability of Atm −/− ; Tdp1 −/− compound mutant mice ( Table 1 and  Supplementary Table 1) . Analysis during development revealed that most Atm −/− ; Tdp1 −/− embryos were smaller than controls and lost viability between E13.5 and E16.5, a stage at which Top1cc levels are maximal (Fig. 1c) . Given that SCAN1 and A-T are neurodegenerative syndromes, we determined the extent to which ATM and Tdp1 loss specifically affects the nervous system. To do this, we used mice in which Atm was inactivated in neural progenitors using Nestin-cre and a conditional Atm allele 39 to generate Atm Nes-cre mice. Atm Nes-cre ; Tdp1 −/− mice showed a similar phenotype to Atm −/− ; Tdp1 −/− mice, with premature lethality between E13.5-16.5, indicating that the lethality following co-inactivation of ATM and Tdp1 was related to effects on the nervous system ( Table 1 and Supplementary Table 1) . To further understand the basis for the genetic interaction between ATM and Tdp1, we considered whether the phenotype of the double mutant mice might actually reflect the established role of ATM in responding to DSBs [8] [9] [10] , rather than a specific function in regulating Top1cc. We generated Tdp1 −/− mutant mice with DNA double-strand break repair deficiency, which included DNA ligase IV deficiency (Tdp1 −/− ; Lig4 Nes-cre ) and the catalytic subunit of the DNA-dependent protein kinase (Tdp1 −/− ; Prkdc −/− ). However, in both cases, the double mutant mice were born at normal Mendelian ratios and did not show any overt phenotype ( Table 1 and Supplementary Table 1) . We also generated Tdp1 −/− ; Mre11 ATLD/ATLD and Tdp1 −/− ; Nbs1 ∆B/∆B double mutant mice to determine whether the MRN complex, which is critical for ATM activation [8] [9] [10] [11] , particularly in the nervous system 5 , is important for ATM activity in the context of Tdp1 inactivation. However, we again found that MRN and Tdp1 double mutants were born at Mendelian frequencies without any apparent phenotype ( Table 1 and Supplementary Table 1) . Collectively, these data indicate that the neuroprotective synergy observed between ATM and Tdp1 likely reflects a role of ATM that is different to its established function in DNA double-strand break signaling and activation by the MRN complex.
ATM and Tdp1 are required for CNS development
To understand how dual loss of ATM and Tdp1 affects the nervous system, we examined mutant embryos at various developmental stages. Immunohistochemical analyses of Atm −/− ; Tdp1 −/− and Atm Nes-cre ; Tdp1 −/− embryos revealed substantial levels of DNA damage, as indicated by γH2AX-positive cells throughout the developing forebrain, midbrain and cerebellum (Fig. 5a and Supplementary Figs. 7 and 8) . Consistent with increased DNA damage, widespread p53 immunostaining and apoptosis was localized primarily in the proliferative ventricular zone (Fig. 5b and Supplementary Figs. 7 and 8 ). This contrasts with observations in wild-type, Atm −/− or Tdp1 −/− embryos, where only sporadic apoptosis and no γH2AX-or p53-immunopositive cells were present (Fig. 5a,b and Supplementary Figs. 7 and 8) .
Although the appearance of γH2AX in Atm −/− ; Tdp1 −/− neural tissues seems to contradict our results showing that ATM is essential for γH2AX formation after CPT (Fig. 4) , these in vivo results reflect Top1cc collision with replication forks, which generates DNA doublestrand breaks, and the subsequent activation of other DNA damageresponsive kinases such as Atr. We also found high levels of apoptosis during early neurogenesis, as revealed by active caspase-3 and TUNEL staining in E12.4 Atm −/− ; Tdp1 −/− embryos (Fig. 5c) . DNA damage or apoptosis was absent outside of the Atm −/− ; Tdp1 −/− and Atm Nes-cre ; Tdp1 −/− embryonic nervous system (data not shown).
Given the synthetic lethality between ATM and Tdp1, and an absence of an overt phenotype after loss of Tdp1 and double-strand break repair factors or regulators of ATM activation, we considered it likely that toxic Top1cc accumulation accounted for the Atm −/− ; Tdp1 −/− phenotype. We found substantially increased Top1cc levels in the double mutants compared to single mutants and controls (Fig. 5d) , despite normal levels of Top1 protein in the double mutant embryos (Fig. 5e) . Given that Top1cc levels were elevated in Atm −/− and Tdp1 −/− neural tissues without associated pathology, our data suggest a DNA damage threshold may exist in neurons.
To directly test the pathogenic consequence of elevated Top1cc, we exposed developing embryos to the CPT analog topotecan (TPT). We found a reduction in embryo size and widespread apoptosis throughout the nervous system in response to TPT administration, which was strikingly reminiscent of the Atm −/− ; Tdp1 −/− phenotype ( Fig. 5f  and Supplementary Fig. 9 ). Atm −/− embryos were hypersensitive to topotecan with neural apoptosis being around twofold that of wild-type embryos (Fig. 5f) . Notably, despite systemic exposure of the embryos to topotecan and its wide bioavailability, we found that apoptosis was almost exclusively confined to the nervous system, underscoring the sensitivity of neural development to this DNA lesion (Supplementary Fig. 9 ).
Because apoptosis can potentially result in Top1cc accumulation 12,23 , we generated Atm −/− ; Tdp1 −/− mice in which p53 was also inactivated, which blocks p53-dependent apoptosis after DNA damage in the nervous system. Although the loss of one or both copies of p53 effectively blocked apoptosis (Fig. 5g) and rescued lethality (data not shown), these triple mutants showed similar Top1cc levels to the Atm −/− ; Tdp1 −/− mice (Fig. 5g) . These data confirm that elevated Top1cc levels in the double mutants result from the inactivation of ATM and Tdp1 and are not an outcome of apoptosis.
Top1ccs occur after endogenous DNA damage Top1cc can also accumulate when these normally transient complexes encounter various types of DNA lesions, including strand breaks and Genetic analysis shows synthetic lethality after coincident loss of Tdp1 and ATM.
Compound mutants involving DNA double-strand break repair (Lig4 or Prkdc) or MRN (Mre11 ATLD/ATLD ) deficiency do not affect the expected rate of generation of compound mutant mice. Mouse genetic inheritance ratios were calculated using standard rules for Mendelian genetic inheritance: expected and observed ratios were calculated on the basis of parental genotypes and the number of live-born mice.
npg a r t I C l e S abasic sites 12, 23 . We asked whether Top1cc accumulation might be a pathologic lesion in other disease-relevant scenarios. To do this, we examined mice with defective Xrcc1, a factor that is central for DNA repair via single-strand break/base excision repair (BER) 15 . Loss of Xrcc1 in the nervous system leads to defective DNA repair and resulting DNA damage accumulation 40 . Conspicuously, increased levels Top1cc were present in Xrcc1 Nes-cre proliferative neural tissue at E14.5, reflecting ATM or Tdp1 loss (Fig. 6a) , further supporting the notion that DNA damage can result in trapped Top1ccs. Notably, we also examined Aptx −/− embryos, in which the adenyl hydrolase Aptx responsible for preventing AOA1 is inactivated, but Top1cc levels were not increased compared to controls (Fig. 6a) . These findings indicate that the type of DNA damage influences Top1cc accumulation. Xrcc1 serves a critical scaffold function during DNA repair and its loss leads to marked destabilization and loss of the repair factor DNA ligase III (Lig3). Because TDP1 is known to interact with Xrcc1, we examined levels of the various BER components to determine whether Xrcc1 deletion results in destabilization of TDP1 (or other repair factors), as it does Lig3. If so, this could explain elevated Top1cc levels after Xrcc1 loss. However, although Lig3 expression was decreased in Xrcc1 Nes-cre brain, all of the other BER factors that we examined showed normal protein levels after Xrcc1 loss, indicating that increased Top1cc in Xrcc1 Nes-cre tissue did not result from destabilization of TDP1 (Fig. 6b) . We next generated (Atm; Xrcc1) Nes-cre mice to determine the consequences of coincident ATM and Xrcc1 inactivation toward Top1cc occurrence. Although Xrcc1 Nes-cre mice show a mild reduction in cerebellar size 40 , dual inactivation of these factors led to marked neural development defects, involving marked cerebellar atrophy and associated Top1cc accumulation in cerebellar tissue (Fig. 6c,d) . Levels of Top1cc were higher during neural development than in the P16 cerebellum (Fig. 6d) , suggesting that, in Xrcc1 Nes-cre tissue, these lesions are detrimental during development. Accordingly, in (Atm; Xrcc1) Nes-cre neural tissue, we observed pronounced apoptosis that commenced from ~E12.5 onwards (data not shown). Although Top1cc levels were elevated after Xrcc1 inactivation, it is likely that the effects of Ctrl Atm Atm
Tdp1
50 µm 300 µm 300 µm npg a r t I C l e S direct DNA strand breaks after Xrcc1 loss also exacerbates the (Atm; Xrcc1) Nes-cre phenotypic abnormalities. These data suggest that Top1cc may be a general DNA lesion that affects the nervous system in DNA repair-deficient human diseases.
DISCUSSION
The precise DNA lesions responsible for neurodegeneration in a spectrum of human genome instability diseases remain unknown. A prime example is that of A-T, a debilitating childhood neurodegenerative syndrome that is associated with defective DNA damage signaling 16 . We found that, in the nervous system, in addition to its activation by DNA double strand breaks [8] [9] [10] , ATM is required to regulate Top1cc, a transient topoisomerase-DNA intermediate that occurs frequently during normal cellular function. Our data indicate that ATM functions in a non-epistatic manner to TDP1 to regulate the fate of trapped Top1cc. However, these factors cooperatively function to reduce Top1cc levels, as indicated by the synergistic rise in Top1ccs in the absence of both proteins. Although Tdp1 has specific enzymatic activity to cleave Top1-DNA adducts, ATM regulates the SUMO/ubiquitin-mediated turnover of Top1. In this regard, the later onset of neurodegeneration in SCAN1 may indicate that Tdp1 function in vivo is comparatively more critical for preventing transcriptionassociated Top1cc accumulation in post-mitotic tissue. Aberrant accumulation of Top1cc must be prevented, as the DNA strand break formed during topoisomerase activity is potentially detrimental to a cell. For example, during proliferation, replication fork collision with trapped Top1ccs can lead to DNA double-strand breaks and cell death. In addition, Top1ccs can be trapped by proximal oxidative DNA breaks that enhance their conversion into DNA damage 24, 41, 42 . Because oxidative stress potentially results in thousands of DNA single-strand breaks each day 15, 43 , it may be a major contributor toward elevation of Top1cc levels in the nervous system, a tissue that carries a high oxidative load. Thus, DNA lesions associated with Top1cc are pervasive throughout the life of the nervous system, and regulation of this topoisomerase complex is a critical genome maintenance requirement in this tissue.
The canonical role of ATM is regulating the response to DNA double-strand breaks 10, 16 . It is likely that this aspect of ATM operates in parallel with Top1cc regulation (Supplementary Fig. 10 ). In the nervous system, DNA double-strand breaks can result in ATMdependent apoptosis 5, 38 , in which ATM activation occurs via the double-strand break-sensing MRN complex 5, 11 . Mutation in the Mre11 component of the MRN complex can lead to ATLD 12 , a neurodegenerative syndrome that is similar to A-T. Because ATLD reflects the importance of the MRN-ATM axis in responding to DNA double-strand breaks, ATM regulation of Top1cc levels implicates an additional prevalent genotoxic lesion in A-T compared with ATLD. The more severe phenotype of A-T compared with that of ATLD, despite both syndromes having an early onset 44 , is consistent with the occurrence of this additional detrimental DNA lesion.
Our study points to an important neuroprotective role for regulation of Top1cc in the nervous system, thereby broadening the understanding of the etiologic lesions that contribute to neurodegenerative syndromes. In addition to A-T and SCAN1, this lesion may have a substantial pathogenic effect in other syndromes associated with DNA repair deficiency and genome instability. Given the requirement for other classes of topoisomerases for multiple DNA transactions 24, 45 , it seems likely that defects in these or factors that modulate their activity will affect neural function. For instance, defective topoisomerase activity has been implicated in autism spectrum disorder 46 npg a r t I C l e S for transcriptional regulation of long genes linked to autism 48 . Furthermore, deficiency in Top3β has recently been identified as an RNA topoisomerase that is important for the function of the FRMP, a factor that prevents Fragile X mental retardation syndrome 49, 50 .
METhODS
Methods and any associated references are available in the online version of the paper. TdP1 overexpression and ATm/TdP1 knockdown analysis. 293T cells were transfected (using FuGene 6) with short-hairpin RNA constructs (Sigma) corresponding to human ATM (shATM; 5′-CCGGGCCGTCAACTAGAACATGA TACTCGAGTATCATGTTCTAGTTGACGGCTTTTTG-3′ and 5′-CCGGCC TTTCATTCAGCCTTTAGAACTCGAGTTCTAAAGGCTGAATGAAAGGTT TTTG-3′) or a "scrambled" control (shScrambled). 24 h following transfection, cells underwent puromycin selection (2 µg ml −1 ) with a media change every 24 h for 10 days. Stable-tranfectants were then re-transfected with shScrambled or shAtm constructs along with either pFlag vector control, pFlag-TDP1 or an shRNA targeting human TDP1 (shTDP1; 5′-CCGGCCGATGAATCAAAGTGG TTATCTCGAGATAACCACTTTGATTCATCGGTTTTTG-3′). Following CPT treatment, cells were lysed and underwent Top1 immunoprecipitation to assess levels of Top1 post-translational modification.
Histology. Pregnant female mice underwent transcardial perfusion with 4% buffered paraformaldehyde (wt/vol, PFA) and harvested embryos were cryoprotected in buffered 25% sucrose (wt/vol) solution. Embryos sectioned sagitally at 10 µm using an HM500M cryostat (Microm). Immunostaining was carried out with the antibodies listed below. For colorimetric visualization of positive signals, sections were incubated with antibodies overnight at room temperature after quenching endogenous peroxidase using 0.6% H 2 O 2 (vol/vol) in methanol. Slides were washed with PBS three times, followed by incubation with biotinylated secondary antibody and avidin-biotin complex (Vectastain Elite kit, Vector Labs). Antibodies were used after citrate buffer-based antigen retrieval. Immunoreactive signals were visualized with the VIP substrate kit (Vector Labs) using the manufacturer's protocol. Sections were counterstained with 0.1% methyl green (wt/vol), dehydrated, and mounted in DPX (Fluka). For fluorescent detection of immunoreactivity, FITC-or Cy3-conjugated secondary antibodies (Jackson Immunologicals) were used and counterstained with 4′6-diamidino-2-phenylindole (DAPI; Vector Laboratories). For immunohistochemistry and immunocytochemistry, we used antibodies to γH2AX (Ser-139, rabbit, 1:200, Cell Signaling, cat# 2577), p53 (clone CM5, rabbit, 1:1,000, Vector Laboratories, cat# VP-P956), PCNA (clone PC10, mouse, 1:500, Santa Cruz, cat# SC-56), Tuj1/β-tubulin III (mouse, 1:1,000, Covance, cat# MMS-435P), Calbindin (mouse, 1:2,000, Clone CB955, Sigma, cat# C9848). Apoptosis was detected without antigen retrieval using antibody to ssDNA (rabbit, 1:300, IBL, cat# 18731). Experiments were performed in triplicate.
For fluorescent labeling of quiescent cortical astrocytes, human fibroblasts or MEFs, cells were grown to confluence on glass coverslips, fixed with 4% PFA in PBS for 10 min and permeabilized for 5 min in 0.5% Triton X-100/PBS. Cells were immunostained with antibodies diluted in PBS/3% BSA to GFAP (rabbit, 1:500, Abcam, cat# 7779), γH2AX (Ser139, rabbit, 1:500, Millipore, cat# JBW301) and 53BP1 (rabbit, 1:500, Bethyl, cat# A300-272A), followed by Alexa 488/555-conjugated secondary antibodies (1:500, catalog #A21206, Life Technologies) or Alexa 488-conjugated phalloidin (1:500, catalog #A12379, Life Technologies) and counterstained with DAPI. Experiments were performed in triplicate.
In situ cell counts. To determine apoptosis indices in the developing embryonal brain, E12.5 or E14.5 embryos were subjected to quantitative analysis. Two embryos for each genotype were analyzed. Immunopositive signals for TUNEL or active caspase-3 were measured within 0.27 mm 2 from at least three representative sections of the neocortex per embryo. All statistics were calculated using unpaired Student's t test. Experiments were performed in duplicate.
Topotecan administration. Topotecan hydrochloride (Hycamtin, Glaxo Smith Kline) is a camptothecin analog that is widely bioavailable and readily penetrates neural tissue. Topotecan was dissolved in 0.9% NaCl (wt/vol) and diluted to a concentration of 100 µg ml −1 . Plugged female mice were administered Topotecan via intraperitoneal injection at a dose of 0.5 µg per g of body weight at E12.5 and E13.5 and then collected E14.5. The female was perfused with 4% PFA and the embryos were collected in PFA and then cryoprotected and processed for sectioning.
Statistics. Bar and line graphs represent mean values of all replicates, error bars represent s.e.m. and P values were calculated using Student's unpaired t test. For comet assays, a minimum of 100 cells for each treatment were counted and experiments were repeated in triplicate (in vitro comet) or quadruplicate (in vivo comet); exact cell numbers/comets are indicated in their respective figure legends. Mean comet tail moments were calculated and graphed. Experimental samples were assigned randomized identity and analysis was performed blind.
For foci quantification experiments, a minimum of 30 cells for each treatment were counted and experiments were repeated in quadruplicate (exact cell numbers/comets are indicated in figure legends). Mean cellular foci values were calculated and graphed. Experimental samples were assigned randomized identity and analysis was performed blind.
Mouse genetic inheritance ratios were calculated using standard rules for Mendelian genetic inheritance. Expected and observed genetic ratios were calculated based upon the actual number of live-born mice (indicated by n). No statistical methods were used to pre-determine sample sizes, but are similar to those generally employed in the field. Data distribution was assumed to be normal, but this was not formally tested.
A Supplementary methods checklist is available.
npg
